Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INTS
#3863
Intensity Therapeutics, Inc. Common stock
7.6
6
+4.64%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+4.64%
Mudança mensal
+1915.79%
Mudança em 6 meses
+2541.38%
Mudança anual
+234.50%
Fechamento anterior
7.3
2
Open
7.6
6
Bid
Ask
Low
7.6
6
High
7.6
6
Volume
1
Mercados
Ações
Cuidados de saúde
INTS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
548.38 K
607.24 K
—
Valuation ratios
Enterprise value
-3.8 M
-1.52 M
-9.12 M
Price to earnings ratio
-0.25
-0.06
-0.17
Price to sales ratio
1.32
—
—
Price to cash flow ratio
0.41
0.06
0.18
Price to book ratio
0.23
0.34
0.47
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.61
3.41
2.6
Return on equity %
0.8
5.59
12.51
Return on invested capital %
1 797.73
4 021.82
—
Gross margin %
100
—
—
Operating margin %
367.77
—
—
EBITDA margin %
—
—
—
Net margin %
464.19
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
3.91
1.92
7.54
Inventory turnover
—
—
—
Asset turnover
0.13
0
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
20.91
27.36
12.71
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
42.94
4.67
13.2
Net current asset value per share
44.87
6.05
17.55
Tangible book value per share
38.19
5.25
12.88
Working capital per share
33.38
2.89
5.87
Book value per share
38.19
5.25
12.88
Notícias
Intensity Therapeutics anuncia desdobramento reverso de ações de 1 para 25
Intensity Therapeutics announces 1-for-25 reverse stock split
What's Going On With Intensity Therapeutics Stock Friday? - Intensity Therapeutics (NASDAQ:INTS)
Intensity Therapeutics define prioridades para 2026 após validação clínica
Intensity therapeutics outlines 2026 priorities after clinical validation
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Ações da Intensity Therapeutics sobem após garantir extensão de listagem na Nasdaq
Intensity Therapeutics stock rises after securing Nasdaq listing extension
Intensity Therapeutics recebe extensão de 180 dias para cumprir regra de preço da Nasdaq
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule
Intensity Therapeutics amplia programa de oferta no mercado para US$ 30 milhões
Intensity Therapeutics expands at-the-market offering program to $30 million